Clementia Pharmaceuticals Inc.
CMTA
CMTA was delisted on the 17th of April, 2019.
48 hedge funds and large institutions have $732M invested in Clementia Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 11 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
155% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 11
108% more capital invested
Capital invested by funds: $352M → $732M (+$380M)
55% more funds holding
Funds holding: 31 → 48 (+17)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
+$15.6M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$12.7M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$7.7M |
| 4 |
WIC
Water Island Capital
New York
|
+$7.17M |
| 5 |
IA
IndexIQ Advisors
New York
|
+$5.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.3M |
| 2 |
PA
Perceptive Advisors
New York
|
-$17.6M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.5M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$11.2M |
| 5 |
AG
Artal Group
Luxembourg
|
-$10M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHS
51
PFM Health Sciences
San Francisco,
California
| – | -$9.99M | -849,904 | Closed |
|
|
SSA
52
Schonfeld Strategic Advisors
New York
| – | -$2.47M | -210,000 | Closed |
|
53
Citadel Advisors
Miami,
Florida
| – | -$2.13M | -181,262 | Closed |
|
|
WMSA
54
Weiss Multi-Strategy Advisers
New York
| – | -$1.24M | -105,000 | Closed |
|
|
UOC
55
UBS O'Connor
Chicago,
Illinois
| – | -$463K | -39,339 | Closed |
|
|
LCM
56
Laurion Capital Management
New York
| – | -$433K | -36,838 | Closed |
|
|
BFM
57
Boothbay Fund Management
New York
| – | -$334K | -28,361 | Closed |
|
58
Northern Trust
Chicago,
Illinois
| – | -$191K | -16,211 | Closed |
|
|
OAM
59
Oxford Asset Management
Oxford,
United Kingdom
| – | -$154K | -13,057 | Closed |
|
CMTA Hedge Fund Activity: Q1 2019 in Review
48 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q1 2019, worth a combined $732M — up 108% from $352M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CMTA positions and 11 closed out — a net gain of 17 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Kite Lake Capital Management (UK), opening a new position worth an estimated $15.6M. The largest seller was Wellington Management Group, cutting an estimated $35.3M.
- 48 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q1 2019, up from 31 in Q4 2018.
- Funds reported $732M of Clementia Pharmaceuticals Inc. stock for Q1 2019, up 108% quarter-over-quarter.
- 28 funds opened new Clementia Pharmaceuticals Inc. positions in Q1 2019 and 11 closed out, a net change of +17 holders.
- The largest Clementia Pharmaceuticals Inc. buyer in Q1 2019 was Kite Lake Capital Management (UK), an estimated $15.6M added.
- The largest Clementia Pharmaceuticals Inc. seller in Q1 2019 was Wellington Management Group, an estimated $35.3M sold.
Based on aggregated 13F filings for Q1 2019.